"Study Name","Acronym","Type","Status","Country","Start Year","Years of Follow-up","Study Design","Recruitment Target","Number of Participants","Number of Participants with biosamples","Population","Sources of Recruitment","Minimum Age","Maximum Age","Number of Participants","Number of Participants with biosamples","Number of Data Collection Events" "Accelerated Cure Project Repository","ACP","Individual Study","Published","United States","2004","9","Registry","Individuals","3220","3220","ACP - Multiple Sclerosis and Other Demyelinating Disease","Other, Specific population","","","2481","2481","2" "Accelerated Cure Project Repository","ACP","Individual Study","Published","United States","2004","9","Registry","Individuals","3220","3220","ACP - Control","General population, Other","","","739","739","2" "British Columbia Multiple Sclerosis Historical Database","BCMS","Individual Study","Draft" "The Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis","CanProCo","Individual Study","Published","","2018","2","Cohort","Individuals","1000","","CanProCo - Foundation cohort","Specific population","18","60","950","","6" "The Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis","CanProCo","Individual Study","Published","","2018","2","Cohort","Individuals","1000","","CanProCo - Foundation cohort (Enriched RIS)","Specific population","18","60","150","","6" "The Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis","CanProCo","Individual Study","Published","","2018","2","Cohort","Individuals","1000","","CanProCo - Foundation cohort (Early RRMS)","Specific population","18","60","200","","6" "The Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis","CanProCo","Individual Study","Published","","2018","2","Cohort","Individuals","1000","","CanProCo - Foundation cohort (Early PPMS)","Specific population","18","60","100","","6" "The Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis","CanProCo","Individual Study","Published","","2018","2","Cohort","Individuals","1000","","CanProCo - Healthy controls","General population, Other","18","60","50","","6" "Corrona Multiple Sclerosis Registry","CMSR","Individual Study","Published","United States","2017","3","Registry","Individuals","1000","","CMSR population","Specific population","18","","1000","","6" "Canadian Pediatric Demyelinating Disease Network","CPDDN","Individual Study","Published","Canada, United States","2004","16","Case-control","Individuals","585","","CPDDN - Children with demyelination","Specific population","","18","452","","19" "Canadian Pediatric Demyelinating Disease Network","CPDDN","Individual Study","Published","Canada, United States","2004","16","Case-control","Individuals","585","","CPDDN - Healthy volunteers","General population","","18","133","","2" "iConquerMS People-Powered Research Network","iConquerMS","Individual Study","Published","United States","2014","6","Registry","Individuals","5500","","iConquerMS population","General population","21","","4920","","9" "Johns Hopkins Precision Medicine Center of Excellence for Multiple Sclerosis","JHMS","Individual Study","Draft" "Veterans Affairs Multiple Sclerosis Surveillance Registry","MSSR","Individual Study","Published","United States","2015","5","Registry","Individuals","1900","","MSSR population","Specific population","18","","1900","","5" "North American Research Committee on Multiple Sclerosis Registry","NARCOMS","Individual Study","Published","","1996","24","Registry","Individuals","41000","","NARCOMS population","General population, Specific population","18","","41000","","41" "North American Registry for Care and Research in Multiple Sclerosis","NARCRMS","Individual Study","Published","Canada, United States","2016","4","Registry","Individuals","712","","NARCRMS population","Specific population","18","65","712","","4" "New York State Multiple Sclerosis Consortium","NYSMSC","Individual Study","Published","United States","1996","24","Registry","Individuals","10100","","NYSMSC population","Specific population","","","10100","","24" "Pediatric Multiple Sclerosis and other Demyelinating Diseases","PeMSDD","Individual Study","Published","United States","2011","9","Registry","Individuals","2500","","PeMSDD population","Specific population","","21","2500","","1" "Sonya Slifka Longitudinal Multiple Sclerosis Study","SLIFKA","Individual Study","Draft"